Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Capital Leases (2017 - 2025)

Historic Capital Leases for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $2.1 million.

  • Organogenesis Holdings' Capital Leases rose 10549.56% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10549.56%. This contributed to the annual value of $718000.0 for FY2024, which is 6197.03% down from last year.
  • Organogenesis Holdings' Capital Leases amounted to $2.1 million in Q3 2025, which was up 10549.56% from $98000.0 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Capital Leases registered a high of $10.5 million during Q1 2021, and its lowest value of $98000.0 during Q2 2025.
  • For the 4-year period, Organogenesis Holdings' Capital Leases averaged around $2.5 million, with its median value being $1.3 million (2024).
  • As far as peak fluctuations go, Organogenesis Holdings' Capital Leases tumbled by 9321.02% in 2021, and later surged by 22686.57% in 2024.
  • Quarter analysis of 4 years shows Organogenesis Holdings' Capital Leases stood at $831000.0 in 2021, then soared by 127.2% to $1.9 million in 2023, then plummeted by 61.97% to $718000.0 in 2024, then surged by 191.64% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $98000.0 for Q2 2025, and $411000.0 during Q1 2025.